|
|
Volumn 6, Issue 27, 2015, Pages 23036-23037
|
|
HIF2a inhibitors for the treatment of VHL disease
a
a
a
|
|
Author keywords
HIF2a inhibitors; Hypoxia; Renal cancer; VHL
|
|
Indexed keywords
HYPOXIA INDUCIBLE FACTOR 2ALPHA;
HYPOXIA INDUCIBLE FACTOR 2ALPHA INHIBITOR;
IRON REGULATORY PROTEIN 1;
PROTEIN INHIBITOR;
UNCLASSIFIED DRUG;
VON HIPPEL LINDAU PROTEIN;
BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR;
ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1;
MESSENGER RNA;
OXYGEN;
TRANSFORMING GROWTH FACTOR BETA;
VASCULOTROPIN A;
VHL PROTEIN, HUMAN;
5' UNTRANSLATED REGION;
ANGIOGENESIS;
CANCER RISK;
CYSTADENOMA;
EDITORIAL;
ERYTHROCYTOSIS;
ERYTHROPOIESIS;
GERMLINE MUTATION;
HEART MUSCLE CONTRACTILITY;
HEMANGIOBLASTOMA;
HOMOZYGOSITY;
HUMAN;
KIDNEY CARCINOMA;
NONHUMAN;
PANCREATIC NEUROENDOCRINE TUMOR;
PHENOTYPE;
PHEOCHROMOCYTOMA;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN STABILITY;
PROTEIN TARGETING;
RISK ASSESSMENT;
VON HIPPEL LINDAU DISEASE;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
CHEMISTRY;
DISEASE MODEL;
GENETICS;
HYPOXIA;
KIDNEY DISEASES;
METABOLISM;
ZEBRA FISH;
ANIMALS;
BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS;
DISEASE MODELS, ANIMAL;
HUMANS;
HYPOXIA;
KIDNEY DISEASES;
OXYGEN;
RNA, MESSENGER;
TRANSFORMING GROWTH FACTOR BETA;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;
ZEBRAFISH;
|
|
EID: 84943423959
PISSN: None
EISSN: 19492553
Source Type: Journal
DOI: 10.18632/oncotarget.4564 Document Type: Editorial |
|
Times cited : (16)
|
|
References (7)
|
